These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29265019)

  • 21. The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues.
    Coulston CM; Perdices M; Tennant CC
    Aust N Z J Psychiatry; 2007 Nov; 41(11):869-84. PubMed ID: 17924240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of dual diagnosis among clinic attending patients in a de-addiction centre of a tertiary care hospital.
    Subodh BN; Hazari N; Elwadhi D; Basu D
    Asian J Psychiatr; 2017 Feb; 25():169-174. PubMed ID: 28262143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Which psychiatric comorbidities in cannabis dependence during adolescence? Comparison of outpatients and controls].
    Dorard G; Bungener C; Phan O; Edel Y; Corcos M; Berthoz S
    Encephale; 2018 Feb; 44(1):2-8. PubMed ID: 27637871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substance use disorders among psychotic patients admitted to inpatient psychiatric care.
    Helseth V; Lykke-Enger T; Johnsen J; Waal H
    Nord J Psychiatry; 2009; 63(1):72-7. PubMed ID: 19034727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dual diagnosis in psychiatric inpatients: prevalence and general characteristics].
    Rodríguez-Jiménez R; Aragüés M; Jiménez-Arriero MA; Ponce G; Muñoz A; Bagney A; Hoenicka J; Palomo T
    Invest Clin; 2008 Jun; 49(2):195-205. PubMed ID: 18717266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Traumatic life events and PTSD among women with substance use disorders and schizophrenia.
    Gearon JS; Kaltman SI; Brown C; Bellack AS
    Psychiatr Serv; 2003 Apr; 54(4):523-8. PubMed ID: 12663840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dual diagnosis in psychoactive substance abusing or dependent persons].
    Błachut M; Badura-Brzoza K; Jarzab M; Gorczyca P; Hese RT
    Psychiatr Pol; 2013; 47(2):335-52. PubMed ID: 23888766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations between psychotic symptoms and substance use in young offenders.
    Degenhardt L; Coffey C; Hearps S; Kinner SA; Borschmann R; Moran P; Patton G
    Drug Alcohol Rev; 2015 Nov; 34(6):673-82. PubMed ID: 26084677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of psychosis remission in psychotic disorders that co-occur with substance use.
    Caton CL; Hasin DS; Shrout PE; Drake RE; Dominguez B; Samet S; Schanzer B
    Schizophr Bull; 2006 Oct; 32(4):618-25. PubMed ID: 16873441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alcohol and substance use by patients with psychosis presenting to an emergency department: changing patterns.
    Latt N; Jurd S; Tennant C; Lewis J; Macken L; Joseph A; Grochulski A; Long L
    Australas Psychiatry; 2011 Aug; 19(4):354-9. PubMed ID: 21851228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Putative psychotic symptoms in the Mexican American population: prevalence and co-occurrence with psychiatric disorders.
    Vega WA; Sribney WM; Miskimen TM; Escobar JI; Aguilar-Gaxiola S
    J Nerv Ment Dis; 2006 Jul; 194(7):471-7. PubMed ID: 16840842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-year recovery outcomes for long-term patients with co-occurring schizophrenic and substance use disorders.
    Xie H; McHugo GJ; Helmstetter BS; Drake RE
    Schizophr Res; 2005 Jun; 75(2-3):337-48. PubMed ID: 15885525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder.
    Miles H; Johnson S; Amponsah-Afuwape S; Finch E; Leese M; Thornicroft G
    Psychiatr Serv; 2003 Apr; 54(4):554-61. PubMed ID: 12663845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substance use in youth at risk for psychosis.
    Carney R; Yung AR; Amminger GP; Bradshaw T; Glozier N; Hermens DF; Hickie IB; Killackey E; McGorry P; Pantelis C; Wood SJ; Purcell R
    Schizophr Res; 2017 Mar; 181():23-29. PubMed ID: 27590573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dual diagnosis of psychosis and addiction. From principles to practice].
    Gouzoulis-Mayfrank E
    Nervenarzt; 2004 Jul; 75(7):642-50. PubMed ID: 15293008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual diagnosis and chronology of illness in treatment-seeking Italian patients dependent on heroin.
    Maremmani AG; Dell'Osso L; Pacini M; Popovic D; Rovai L; Torrens M; Perugi G; Maremmani I
    J Addict Dis; 2011 Apr; 30(2):123-35. PubMed ID: 21491294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences.
    Margolese HC; Malchy L; Negrete JC; Tempier R; Gill K
    Schizophr Res; 2004 Apr; 67(2-3):157-66. PubMed ID: 14984874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis.
    Corcoran CM; Kimhy D; Stanford A; Khan S; Walsh J; Thompson J; Schobel S; Harkavy-Friedman J; Goetz R; Colibazzi T; Cressman V; Malaspina D
    Schizophr Res; 2008 Dec; 106(2-3):286-93. PubMed ID: 18809298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients.
    Sokolski KN; Cummings JL; Abrams BI; DeMet EM; Katz LS; Costa JF
    J Clin Psychiatry; 1994 Sep; 55(9):380-7. PubMed ID: 7929017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective.
    Hambrecht M; Häfner H
    Aust N Z J Psychiatry; 2000 Jun; 34(3):468-75. PubMed ID: 10881971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.